Sight Diagnostics is revolutionizing blood testing with its OLO® Technology, providing fast, accurate, and convenient diagnostics in a compact platform. The company's mission is to improve patient care by offering actionable diagnostics anytime, anywhere, and in any clinical condition. Developed over nearly a decade of research, their technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics, and computer science.

Their first product, Parasight™, has successfully diagnosed malaria in nearly 1 million tests across 24 countries. Their latest innovation, Sight OLO®, digitizes blood with only 2 drops of a finger prick or venous sample, providing lab-grade CBC results in minutes. The team at Sight is committed to the social impact their technology represents, and they are known for their cross-disciplinary collaboration and non-hierarchical structure.

With a leadership team dedicated to making a positive change in the world, Sight Diagnostics is leading the way in transforming health systems and patient outcomes with their machine vision and AI technology. Join them in their mission to provide better testing and treatment for both physicians and patients